As of May 26
| -0.16 / -1.25%|
The 5 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 13.00, with a high estimate of 25.00 and a low estimate of 12.00. The median estimate represents a +3.26% increase from the last price of 12.59.
The current consensus among 6 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.